The Current Ratio as of December 2024 (TTM) for Selecta Biosciences, Inc. (SELB) is 1.33

According to Selecta Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.33. This represents a change of -65.07% compared to the average of 3.81 of the last 4 quarters.

Selecta Biosciences, Inc. (SELB) Historical Current Ratio (quarterly & annually)

How has SELB Current Ratio performed in the past?

The mean historical Current Ratio of Selecta Biosciences, Inc. over the last ten years is 3.78. The current 1.33 Current Ratio has changed 3.42% with respect to the historical average. Over the past ten years (40 quarters), SELB's Current Ratio was at its highest in in the September 2016 quarter at 10.84. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Selecta Biosciences, Inc. (SELB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Selecta Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Selecta Biosciences, Inc. (SELB) Average Current Ratio

How has SELB Current Ratio performed in the past?

The current Current Ratio of Selecta Biosciences, Inc. (SELB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Selecta Biosciences, Inc. (SELB) Current Ratio vs. Peers

How is SELB’s Current Ratio compared to its peers?

Selecta Biosciences, Inc.’s Current Ratio is less than Paratek Pharmaceuticals, Inc. (3.66), greater than Corvus Pharmaceuticals, Inc. (0.92), less than Immutep Limited (13.81), less than Icosavax, Inc. (18.06), greater than Checkpoint Therapeutics, Inc. (0.29), greater than Mustang Bio, Inc. (0.40), greater than Reviva Pharmaceuticals Holdings, Inc. (0.39), greater than Fortress Biotech, Inc. (1.23), less than Kodiak Sciences Inc. (8.42), greater than Reviva Pharmaceuticals Holdings, Inc. (0.39), greater than Eyenovia, Inc. (0.74), less than Cognition Therapeutics, Inc. (2.11), less than TransCode Therapeutics, Inc. (1.58), greater than Gamida Cell Ltd. (0.35), less than Rigel Pharmaceuticals, Inc. (1.96), less than Geron Corporation (2.89), less than ImmunoGen, Inc. (5.47), less than Cidara Therapeutics, Inc. (3.54), greater than Fortress Biotech, Inc. (1.23),

Build a custom stock screener for Selecta Biosciences, Inc. (SELB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Selecta Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Selecta Biosciences, Inc. (SELB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Selecta Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.